California Public Employees Retirement System Purchases 78,459 Shares of UiPath Inc. (NYSE:PATH)

California Public Employees Retirement System boosted its holdings in shares of UiPath Inc. (NYSE:PATH) by 13.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 641,825 shares of the healthcare company’s stock after purchasing an additional 78,459 shares during the quarter. California Public Employees Retirement System’s holdings in UiPath were worth $15,943,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. 180 Wealth Advisors LLC lifted its holdings in shares of UiPath by 0.3% in the 4th quarter. 180 Wealth Advisors LLC now owns 188,950 shares of the healthcare company’s stock valued at $4,497,000 after acquiring an additional 492 shares during the last quarter. Bleakley Financial Group LLC boosted its holdings in shares of UiPath by 4.9% in the 4th quarter. Bleakley Financial Group LLC now owns 12,691 shares of the healthcare company’s stock worth $315,000 after purchasing an additional 598 shares during the period. Simplicity Solutions LLC increased its position in shares of UiPath by 4.9% during the 4th quarter. Simplicity Solutions LLC now owns 12,691 shares of the healthcare company’s stock valued at $315,000 after purchasing an additional 598 shares during the last quarter. Arizona State Retirement System lifted its position in UiPath by 0.8% in the third quarter. Arizona State Retirement System now owns 97,951 shares of the healthcare company’s stock worth $1,676,000 after buying an additional 733 shares during the last quarter. Finally, Axxcess Wealth Management LLC boosted its stake in UiPath by 2.6% during the third quarter. Axxcess Wealth Management LLC now owns 29,121 shares of the healthcare company’s stock worth $498,000 after buying an additional 740 shares during the period. Institutional investors own 62.50% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on PATH. Evercore ISI lifted their price target on shares of UiPath from $24.00 to $27.00 and gave the stock an “in-line” rating in a research note on Thursday, March 14th. Wells Fargo & Company raised their price target on UiPath from $24.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Thursday, March 14th. BMO Capital Markets increased their target price on UiPath from $24.00 to $28.00 and gave the stock a “market perform” rating in a research note on Thursday, March 14th. Canaccord Genuity Group boosted their target price on shares of UiPath from $27.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, March 15th. Finally, KeyCorp assumed coverage on shares of UiPath in a report on Monday, April 8th. They set an “overweight” rating and a $27.00 price objective for the company. Nine analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $27.41.

Insider Buying and Selling at UiPath

In other news, CFO Ashim Gupta sold 16,000 shares of the company’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $22.84, for a total transaction of $365,440.00. Following the transaction, the chief financial officer now owns 87,505 shares in the company, valued at $1,998,614.20. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Over the last ninety days, insiders sold 72,000 shares of company stock worth $1,591,360. 31.03% of the stock is owned by insiders.

UiPath Trading Up 1.6 %

Shares of UiPath stock opened at $19.77 on Tuesday. UiPath Inc. has a one year low of $12.38 and a one year high of $27.87. The company has a 50-day simple moving average of $22.08 and a two-hundred day simple moving average of $21.64.

UiPath (NYSE:PATH) last posted its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.10. The company had revenue of $405.25 million during the quarter, compared to analysts’ expectations of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. As a group, sell-side analysts anticipate that UiPath Inc. will post -0.04 earnings per share for the current year.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.